Adamis Pharmaceuticals Corp - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - December 9, 2013

Attached files

file filename
S-1/A - Adamis Pharmaceuticals Corpadmp-s1a_120913.htm
EX-3.3 - CERTIFICATE OF AMENDMENT TO THE - Adamis Pharmaceuticals Corpex3-3.htm
EX-5.1 - DECEMBER 9, 2013 - Adamis Pharmaceuticals Corpex5-1.htm
EX-1.1 - 3,100,000 SHARES - Adamis Pharmaceuticals Corpex1-1.htm
EX-4.2 - FORM OF REPRESENTATIVE S WARRANT AGREEMENT - Adamis Pharmaceuticals Corpex4-2.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Amendment No. 2 to the Registration Statement No. 333-192372 of our report dated July 3, 2013 which report includes an explanatory paragraph as to an uncertainty with respect to Adamis Pharmaceuticals Corporation and Subsidiaries’ (“Company”) ability to continue as a going concern, relating to the consolidated financial statements of the Company as of and for the years ended March 31, 2013, and 2012 and to the reference of our firm under the heading of “Experts” in the prospectus.

 

 

/s/ Mayer Hoffman McCann P.C.

Boca Raton, Florida

December 9, 2013

 

 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports